Actinium Pharmaceuticals, Inc. (ATNM)
NYSEAMERICAN: ATNM · Real-Time Price · USD
1.600
+0.090 (5.96%)
At close: Aug 13, 2025, 4:00 PM
1.600
0.00 (0.00%)
After-hours: Aug 13, 2025, 6:30 PM EDT
Actinium Pharmaceuticals Market Cap
Actinium Pharmaceuticals has a market cap or net worth of $49.91 million as of August 13, 2025. Its market cap has decreased by -78.57% in one year.
Market Cap
49.91M
Enterprise Value
-9.97M
1-Year Change
-78.57%
Ranking
Category
Stock Price
$1.60
Market Cap Chart
Since December 27, 2012, Actinium Pharmaceuticals's market cap has increased from $16.70M to $49.91M, an increase of 198.88%. That is a compound annual growth rate of 9.05%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 12, 2025 | 47.10M | 19.85% |
Dec 31, 2024 | 39.30M | -71.79% |
Dec 29, 2023 | 139.30M | -48.67% |
Dec 30, 2022 | 271.40M | 104.98% |
Dec 31, 2021 | 132.40M | 24.91% |
Dec 31, 2020 | 106.00M | 195.26% |
Dec 31, 2019 | 35.90M | -19.87% |
Dec 31, 2018 | 44.80M | -15.63% |
Dec 29, 2017 | 53.10M | 8.81% |
Dec 30, 2016 | 48.80M | -64.04% |
Dec 31, 2015 | 135.70M | -23.20% |
Dec 31, 2014 | 176.70M | 26.85% |
Dec 31, 2013 | 139.30M | 734.13% |
Dec 31, 2012 | 16.70M | - |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 574.04B |
Johnson & Johnson | 416.11B |
AbbVie | 350.91B |
UnitedHealth Group | 236.90B |
AstraZeneca | 232.33B |
Novartis AG | 230.64B |
Abbott Laboratories | 228.03B |
Novo Nordisk | 223.00B |